Added value of molecular karyotype in childhood acute lymphoblastic leukemia

Added value of molecular karyotype in childhood acute lymphoblastic leukemia

Abstract Background Thanks to an improved therapeutic regimen in childhood B‐cell precursor acute lymphoblastic leukemia (BCP‐ALL), 5 year‐overall survival now exceeds 90%. Unfortunately, the 25% of children who relapse have an initial poor prognosis, potentially driven by pre‐existing or emerging m...

Full description

Bibliographic Details
Main Authors: Margaux Camuset, Baptiste Le Calvez, Olivier Theisen, Catherine Godon, Audrey Grain, Caroline Thomas, Marie‐Laure Couec, Marie C. Béné, Fanny Rialland, Marion Eveillard
Format: Article
Language:English
Published: Wiley 2023-12-01
Series:Cancer Innovation
Subjects:
BCP‐ALL
karyotype
pediatric patients
prognosis
SNP array
Online Access:https://doi.org/10.1002/cai2.67

Internet

https://doi.org/10.1002/cai2.67

Similar Items